Data updated: Mar 10, 2026
TORSEMIDE
TORSEMIDE
Approved 2002-05-14
11
Indications
--
Phase 3 Trials
23
Years on Market
Details
- Status
- Discontinued
- First Approved
- 2002-05-14
- Routes
- INTRAVENOUS, ORAL
- Dosage Forms
- SOLUTION, TABLET
Companies
Hikma STRIDES PHARMA INTL Teva Aurobindo Pharma HETERO LABS LTD III COREPHARMA Sun Pharma AM REGENT PLIVA PHARM IND
Active Ingredient: TORSEMIDE
Website: ↗
TORSEMIDE Approval History
Loading approval history...
What TORSEMIDE Treats
11 FDA approvalsOriginally approved for its first indication in 2002 . Covers 11 distinct patient populations.
- Other (11)
Other
(11 approvals)- • Approved indication (May 2002)
- • Approved indication (May 2003)
- • Approved indication (May 2003)
- • Approved indication (Mar 2005)
- • Approved indication (May 2005)
- • Approved indication (Oct 2007)
- • Approved indication (Feb 2008)
- • Approved indication (Jun 2008)
- • Approved indication (Jan 2009)
- • Approved indication (Apr 2010)
- • Approved indication (Mar 2011)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
TORSEMIDE FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.